HomeARCT • NASDAQ
Arcturus Therapeutics Holdings Inc
$21.03
2.79%
+0.57 Today
After Hours:
$21.33
(1.43%)+0.30
Closed: Sep 22, 7:21:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
-20M020M40M
Revenue
Net Income
Revenue
Net income
(USD)Jun 2025Y/Y change
Revenue
28.30M-43.24%
Operating expense
36.59M-45.07%
Net income
-9.18M46.68%
Net profit margin
-32.446.05%
Earnings per share
-0.3446.88%
EBITDA
-10.84M46.40%
Effective tax rate
-0.04%
0100M200M300M
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Jun 2025Y/Y change
Cash and short-term investments
196.47M-24.53%
Total assets
309.27M-20.42%
Total liabilities
78.22M-39.84%
Total equity
231.05M
Shares outstanding
27.15M
Price to book
2.40
Return on assets
-9.06%
Return on capital
-10.87%
-20M-10M0
Net Change in Cash
Net change in cash
(USD)Jun 2025Y/Y change
Net income
-9.18M46.68%
Cash from operations
-5.76M80.91%
Cash from investing
0.00100.00%
Cash from financing
-14.73M-712.82%
Net change in cash
-20.48M27.03%
Free cash flow
-19.73M23.68%
StockUS listed security
Previous close
$20.46
Day range
$20.18 - $21.66
Year range
$8.04 - $25.88
Market cap
571.06M USD
Avg Volume
735.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA, messenger RNA, gene editing RNA, DNA, antisense oligonucleotides, and microRNA. The company develops RNA therapeutics for the treatment of rare diseases such as ornithine transcarbamylase deficiency, and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19 and an influenza vaccine in the preclinical development phase. The vaccine for COVID-19 was authorised in Japan in 2023 and the European Union in 2025. Wikipedia
Founded
2013
Employees
175
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Finance
Search
Clear search
Close search
Main menu
Google apps